申请人:Bayer Aktiengesellschaft
公开号:US20200031775A1
公开(公告)日:2020-01-30
The present application relates to novel substituted N-arylethyl-2-arylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and inflammatory disorders.
本申请涉及新型取代N-芳基乙基-2-芳基喹啉-4-羧酰胺衍生物,其制备方法,其单独或组合用于治疗和/或预防疾病的用途,以及其用于生产治疗和/或预防疾病的药物的用途,特别是用于治疗和/或预防纤维化和炎症性疾病。